Results
DocMorris Raises 2026 Guidance, Revenue Up 12.5%
DocMorris reported external revenue of CHF 627.8 million, up 12.5% YoY in H1 2026.
Prescription medicines revenue grew 38.3% (45.8% in Q2), prompting a revised full‑year Rx growth outlook of ~40% vers
